New borns in Kinshasa Mother with baby on back and Donkey Mothers with their babies at the Kibaoni Health Center in Ifakara, Tanzania for postpartum care and education.
Ntcheu ANC queue, Malawi Women and child under net Women at Ghana ANC

Malaria in Pregnancy Consoritum and APMEN

10th October 2017, Bali Indonesia

On 10-12 Oct 2017, approximately 110 representatives from 18 malaria endemic countries including malaria researchers in the Asia-Pacific region and elsewhere came together for a 2.5-day meeting in Bali, Indonesia as part of the Asia-Pacific Malaria Elimination Network (APMEN). One full day was dedicated to malaria in pregnancy (MiP) to discuss the results of recent treatment and prevention studies that were completed in the region with potentially policy relevant findings. The meeting consisted of discussions about the burden and treatment (case-management) of malaria in pregnancy in the morning, with 4 presentations followed by a 1 hour break out session to discuss policy implications and then reporting back to plenary before lunch. In the afternoon, the focus was on prevention strategies following the same structure.

For the full conference report please Click Here


What we do arrow

Ten major projects direct research in four key areas of malaria in pregnancy: burden assessment, treatment, prevention and how best to scale up existing strategies and interventions. We work in the following areas of research:



Meet the team arrow

Special features on our research team members around the world.

Latest Research arrow


Burden and impact of Plasmodium vivax in
pregnancy: A multi-centre prospective
observational study

June 2017

First-Trimester artemisinn derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies

May 2017

Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi

November 2016

Cost effectiveness of intermittent
screening followed by treatment
versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non‑inferiority trial

September 2016

Scheduled Intermittant Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittant Preventative Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomised Control Trial

September 2016

Evaluation and Acceptability of a Simplified Test of Visual Function at Birth in a Limited-Resource Setting

June 2016

Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy

June 2016

Effectiveness of the delivery of interventions to prevent malaria in pregnancy in Kenya

April 2016

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria

March 2016

Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study

(February 2016)


Non-falciparum malaria infections in pregnant women in West Africa.

(January 2016)


Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya.

(January 2016)




Latest News arrow


Research Team finds no adverse risk to use of common antimalarials in first trimester pregnancy

May 2017

MiP West Africa Regional Meeting: Togo

April 2017

MiP East Africa Regional Meeting

July 2016

The Malaria in Pregnancy consortium has joined forces with the Worldwide Antimalarial Resistance Network (WWARN)

March 2016


64th Annual Meeting

October 25-29, 2015

Overview Symposium #95:

Overview Symposium #114:

October 2015

2015 Annual Global Costs for Malaria Control, Elimination and Research


Global Call to Action to increase national coverage with Intermittent Preventive Treatment of Malaria in Pregnancy

April 2015


Clinical trials not immune from poor quality drugs

Feb 2015


Leading researchers call for tighter control over medicines used in clinial trials

Feb 2015